Dr reddy s laboratories ltd
WebApr 12, 2024 · Dr. Reddy`s Laboratories Ltd. - ADR (RDY) shares closed 1.5% higher than its previous 52 week high, giving the company a market cap of $9B. The stock is … WebApr 14, 2024 · Dr. Reddy’s Laboratories Limited (NYSE:RDY – Get Rating)’s share price hit a new 52-week high during trading on Wednesday .The stock traded as high as $60.28 and last traded at $60.23, with ...
Dr reddy s laboratories ltd
Did you know?
Web1 day ago · Stocks that were in focus including names like TCS and Infosys which closed higher ahead of results while Dr Reddy’s Laboratories rose more than 2% to hit a fresh 52-week high on Wednesday. Here's what Naveen Mishra, Senior Research Analyst - Equity Research at CapitalVia Global Research Ltd recommends investors should do with … WebDr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfoli...
WebGain a 360-degree view of Dr. Reddy's Laboratories Ltd and make more informed decisions for your business Unlock full profile. Headquarters India. Address 8-2-337, … WebWe started in 1984 with a modest investment and a bold vision. Today, with research and development centres, manufacturing facilities and commercial. presence across the … Investors - Dr. Reddy’s Laboratories – Good Health Can’t Wait Talented people have played a major role in powering and defining the growth of Dr. … Who We Are - Dr. Reddy’s Laboratories – Good Health Can’t Wait For any Dr. Reddy’s product availability related issues, please contact us: …
WebJun 30, 2024 · Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) announced the launch of Icosapent Ethyl Capsules, 1 gram approved by the U.S. Food and Drug Administration (USFDA). Dr. Reddy’s Icosapent Ethyl Capsules, 1 gram … WebJun 22, 2024 · See 33 recent research reports for DRREDDY, BSE:500124 Dr. Reddy's Laboratories Ltd. from 10 source(s) with an average share price target of 5116. Dr. Reddy's Laboratories Ltd. Brokerage/Research Reports, analyst Research Reports - page 2
Web2 days ago · Dr. Reddy's Laboratories, incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 79321.04 Crore) operating in Pharmaceuticals …
Web1 day ago · Stocks that were in focus including names like TCS and Infosys which closed higher ahead of results while Dr Reddy’s Laboratories rose more than 2% to hit a fresh … new orleans mayor reelectionWebFind the latest Dr. Reddy's Laboratories Limited (RDY) stock quote, history, news and other vital information to help you with your stock trading and investing. new orleans mayor party affiliationWeb34 rows · Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries, together referred to as “Dr. Reddy’s”) confirms it had … new orleans mayor goes to jailWebApr 11, 2024 · Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets … new orleans mayor office contactWebApr 13, 2024 · Dr. Reddy`s Laboratories Ltd. - ADR (RDY) shares closed today at 0.3% below its 52 week high of $60.45, giving the company a market cap of $10B. The stock is … new orleans mayor vehementlyWebDr Reddy's Laboratories is a 25–year old company catering to the needs of the pharmaceutical sector. Dr Reddy's started its operation in 1984 i... On 15 March 2013, we lost Dr. K Anji Reddy ... new orleans mayorsWebNov 21, 2024 · Dr. Reddy’s was founded in 1984 by Dr Anji Reddy and started as a small ingredients’ manufacturer. Over the years, the firm expanded into various markets and product lines and became one of the top pharmaceutical companies in India. Dr. Reddy’s credentials and its capabilities are depicted in Exhibit 2. introduction to plants